Endotronix Stock

endotronix.comHealthcareFounded: 2007Funding to Date: $130.19MM

Endotronix is a digital health medtech company and developer of an integrated platform designed to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.

Register for Details

For more details on financing and valuation for Endotronix, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Nicolas Chronos MD
Executive Vice President, Strategy & Clinical Affairs
Michael Nagy
Co-Founder & Chief Technology Officer
Harry Rowland Ph.D
Co-Founder, Chief Executive Officer & Board Member
John Flavin
Chief Financial Officer
Tyler Panian
Director of Mechanical Engineering
Katrin Leadley MD
Chief Medical Officer

Board Members

Fouad Azzam Ph.D
Life Sciences Partners
Gerry Brunk
Lumira Ventures
Harry Rowland Ph.D
James Hummer
Jennifer McMahon
Seroba Life Sciences
Marc Goldberg JD
BioVentures Investors
Paul LaViolette
SV Health Investors
Robert Zieserl
Stanley Lynall
OSF Ventures

Other companies like Endotronix in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$263MM

News

/PRNewswire/ -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion...
Endotronix said today that it closed on a $45 million Series D round for the Cordella cardiovascular monitoring technology it’s developing. The Lisle, Ill.-based company said its latest raise was led by LSP and included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments and an unnamed […]